Zobrazeno 1 - 10
of 198
pro vyhledávání: '"Kazmirski S"'
Autor:
Rojas LA; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.) arojas@fulcrumtx.com., Valentine E; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Accorsi A; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Maglio J; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Shen N; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Robertson A; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Kazmirski S; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Rahl P; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Tawil R; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Cadavid D; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Thompson LA; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Ronco L; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Chang AN; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Cacace AM; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.)., Wallace O; Fulcrum Therapeutics, Cambridge, Massachusetts (L.A.R., E.V., A.A., J.M., N.S., A.R., S.K., P.R., D.C., L.A.T., L.R., A.N.C., A.M.C., O.W.) and University of Rochester Medical Center, Department of Neurology, Rochester, New York (R.T.).
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2020 Sep; Vol. 374 (3), pp. 489-498. Date of Electronic Publication: 2020 Jun 23.
Autor:
Johannes JW, Bates S, Beigie C, Belmonte MA, Breen J, Cao S, Centrella PA, Clark MA, Cuozzo JW, Dumelin CE, Ferguson AD, Habeshian S, Hargreaves D, Joubran C, Kazmirski S, Keefe AD, Lamb ML, Lan H, Li Y, Ma H, Mlynarski S, Packer MJ, Rawlins PB, Robbins DW, Shen H, Sigel EA, Soutter HH, Su N, Troast DM, Wang H, Wickson KF, Wu C, Zhang Y, Zhao Q, Zheng X, Hird AW
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2017 Oct 18; Vol. 8 (11), pp. 1204. Date of Electronic Publication: 2017 Oct 18 (Print Publication: 2017).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Johannes JW; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Bates S; AstraZeneca R&D Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Beigie C; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Belmonte MA; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Breen J; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Cao S; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China., Centrella PA; X-Chem Pharmaceuticals , 100 Beaver Street, Waltham, Massachusetts 02453, United States., Clark MA; X-Chem Pharmaceuticals , 100 Beaver Street, Waltham, Massachusetts 02453, United States., Cuozzo JW; X-Chem Pharmaceuticals , 100 Beaver Street, Waltham, Massachusetts 02453, United States., Dumelin CE; X-Chem Pharmaceuticals , 100 Beaver Street, Waltham, Massachusetts 02453, United States., Ferguson AD; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Habeshian S; X-Chem Pharmaceuticals , 100 Beaver Street, Waltham, Massachusetts 02453, United States., Hargreaves D; AstraZeneca R&D Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Joubran C; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Kazmirski S; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Keefe AD; X-Chem Pharmaceuticals , 100 Beaver Street, Waltham, Massachusetts 02453, United States., Lamb ML; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Lan H; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China., Li Y; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China., Ma H; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China., Mlynarski S; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Packer MJ; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Rawlins PB; AstraZeneca R&D Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Robbins DW; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Shen H; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China., Sigel EA; X-Chem Pharmaceuticals , 100 Beaver Street, Waltham, Massachusetts 02453, United States., Soutter HH; X-Chem Pharmaceuticals , 100 Beaver Street, Waltham, Massachusetts 02453, United States., Su N; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Troast DM; X-Chem Pharmaceuticals , 100 Beaver Street, Waltham, Massachusetts 02453, United States., Wang H; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Wickson KF; AstraZeneca R&D Cambridge Science Park , Unit 310 Darwin Building, Cambridge CB4 0WG, United Kingdom., Wu C; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China., Zhang Y; X-Chem Pharmaceuticals , 100 Beaver Street, Waltham, Massachusetts 02453, United States., Zhao Q; Pharmaron Beijing Co., Ltd. 6 Taihe Road BDA, Beijing 100176 P. R. China., Zheng X; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Hird AW; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2016 Dec 27; Vol. 8 (2), pp. 239-244. Date of Electronic Publication: 2016 Dec 27 (Print Publication: 2017).
Autor:
Gu C; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States. Electronic address: chungang.gu@astrazeneca.com., Lamb ML; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States. Electronic address: michelle.lamb@astrazeneca.com., Johannes JW; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Sylvester MA; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Eisman MS; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Harrison RA; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Hu H; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Kazmirski S; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Mikule K; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Peng B; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Su N; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Wang W; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Ye Q; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Zheng X; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Lyne PD; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Scott DA; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2016 Oct 01; Vol. 26 (19), pp. 4775-4780. Date of Electronic Publication: 2016 Aug 12.
Autor:
Johannes JW; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Almeida L; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Daly K; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Ferguson AD; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Grosskurth SE; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Guan H; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Howard T; AstraZeneca R&D Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom., Ioannidis S; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Kazmirski S; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Lamb ML; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Larsen NA; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Lyne PD; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Mikule K; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Ogoe C; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Peng B; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Petteruti P; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Read JA; AstraZeneca R&D Building 310, Milton Science Park, Cambridge CB4 0WG, United Kingdom., Su N; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Sylvester M; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Throner S; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Wang W; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Wang X; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Wu J; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Ye Q; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Yu Y; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Zheng X; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Scott DA; AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States.
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2015 Dec 15; Vol. 25 (24), pp. 5743-7. Date of Electronic Publication: 2015 Oct 27.
Autor:
Johannes JW; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Almeida L; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Barlaam B; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Boriack-Sjodin PA; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Casella R; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Croft RA; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Dishington AP; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Gingipalli L; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Gu C; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Hawkins JL; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Holmes JL; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Howard T; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Huang J; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Ioannidis S; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Kazmirski S; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Lamb ML; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., McGuire TM; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Moore JE; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Ogg D; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Patel A; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Pike KG; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Pontz T; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Robb GR; AstraZeneca R&D Alderley Park , Macclesfield, Cheshire SK10 4TG, United Kingdom., Su N; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Wang H; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Wu X; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Zhang HJ; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Zhang Y; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Zheng X; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States., Wang T; AstraZeneca R&D Boston , 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2015 Jan 13; Vol. 6 (3), pp. 254-9. Date of Electronic Publication: 2015 Jan 13 (Print Publication: 2015).
Autor:
Rawls, Alan1 (AUTHOR) alan.rawls@asu.edu, Diviak, Bridget K.1,2 (AUTHOR) cismith@asu.edu, Smith, Cameron I.1,2 (AUTHOR) gwsevers@asu.edu, Severson, Grant W.1,2 (AUTHOR) saacost6@asu.edu, Acosta, Sofia A.1,2 (AUTHOR), Wilson-Rawls, Jeanne1 (AUTHOR) alan.rawls@asu.edu
Publikováno v:
Biomolecules (2218-273X). Oct2023, Vol. 13 Issue 10, p1536. 31p.
Autor:
Doig P; Discovery Sciences, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States. Electronic address: Peter.Doig@astrazeneca.com., Boriack-Sjodin PA; Discovery Sciences, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Dumas J; Infection Innovative Medicines, AstraZeneca R&D Boston, Waltham, MA 02451, United States., Hu J; Discovery Sciences, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Itoh K; Wakunaga Pharmaceutical Co. Ltd, Akitakata City, Hiroshima 739-1195, Japan., Johnson K; Infection Innovative Medicines, AstraZeneca R&D Boston, Waltham, MA 02451, United States., Kazmirski S; Discovery Sciences, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, United States., Kinoshita T; Wakunaga Pharmaceutical Co. Ltd, Akitakata City, Hiroshima 739-1195, Japan., Kuroda S; Wakunaga Pharmaceutical Co. Ltd, Akitakata City, Hiroshima 739-1195, Japan., Sato TO; Wakunaga Pharmaceutical Co. Ltd, Akitakata City, Hiroshima 739-1195, Japan., Sugimoto K; Wakunaga Pharmaceutical Co. Ltd, Akitakata City, Hiroshima 739-1195, Japan., Tohyama K; Wakunaga Pharmaceutical Co. Ltd, Akitakata City, Hiroshima 739-1195, Japan., Aoi H; Wakunaga Pharmaceutical Co. Ltd, Akitakata City, Hiroshima 739-1195, Japan., Wakamatsu K; Wakunaga Pharmaceutical Co. Ltd, Akitakata City, Hiroshima 739-1195, Japan., Wang H; Infection Innovative Medicines, AstraZeneca R&D Boston, Waltham, MA 02451, United States.
Publikováno v:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2014 Nov 01; Vol. 22 (21), pp. 6256-69. Date of Electronic Publication: 2014 Sep 16.
Autor:
Nizi, Maria Giulia1 (AUTHOR) chiarasarnari97@outlook.it, Sarnari, Chiara1 (AUTHOR), Tabarrini, Oriana1 (AUTHOR) mariagiulia.nizi@libero.it
Publikováno v:
Molecules. Aug2023, Vol. 28 Issue 15, p5849. 27p.